HIV-1 co/super-infection in intravenous drug users

Ramos, 2002, Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users., J Virol, 76, 7444, 10.1128/JVI.76.15.7444-7452.2002

Altfeld, 2002, HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus., Nature, 420, 434, 10.1038/nature01200

Koelsch, 2003, Clade B HIV-1 superinfection with wild-type virus after primary infection with drug-resistant clade B virus., AIDS, 17, F11, 10.1097/00002030-200305020-00001

Korber, 2001, Evolutionary and immunological implications of contemporary HIV-1 variation., Br Med Bull, 58, 19, 10.1093/bmb/58.1.19

Op de Coul, 2001, Using phylogenetic analysis to trace HIV-1 migration among western European injecting drug users seroconverting from 1984 to 1997., AIDS, 15, 257, 10.1097/00002030-200101260-00017

Liitsola, 1998, HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad., AIDS, 12, 1907, 10.1097/00002030-199814000-00023

Liitsola, 2000, An outbreak of the circulating recombinant form AECM240 HIV-1 in the Finnish injection drug user population., AIDS, 14, 2613, 10.1097/00002030-200011100-00028

Delgado, 2002, Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure., J Acquir Immune Defic Syndr, 29, 536, 10.1097/00126334-200204150-00016

Paraskevis, 2000, Molecular characterization of a recombinant HIV type 1 isolate (A/G/E/?): unidentified regions may be derived from parental subtype E sequences., AIDS Res Hum Retroviruses, 16, 845, 10.1089/08892220050042783

Yerly, 2001, Acute HIV infection: impact on the spread of HIV and transmission., AIDS, 15, 2287, 10.1097/00002030-200111230-00010

Yerly, 2001, Nosocomial outbreak of multiple bloodborne viral infections., JID, 184, 369, 10.1086/322036

Tyndall, 2003, Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic., AIDS, 17, 887, 10.1097/00002030-200304110-00014

Cuevas, 2002, High HIV-1 genetic diversity in Cuba., AIDS, 16, 1643, 10.1097/00002030-200208160-00010

Gottlieb, 2004, Dual HIV-1 infection associated with rapid disease progression., Lancet, 363, 619, 10.1016/S0140-6736(04)15596-7

Shibata, 1996, Nigida SM Jr. Matthews T, et al. Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1., J Virol, 70, 4361, 10.1128/JVI.70.7.4361-4369.1996

Stephens, 1997, Infected macaques that controlled replication of SIVmac or nonpathogenic SHIV developed sterilizing resistance against pathogenic SHIV (KU-1)., Virology, 234, 328, 10.1006/viro.1997.8662

Stahl-Hennig, 1996, Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus., J Virol, 77, 2969, 10.1099/0022-1317-77-12-2969

Barker, 1998, Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome., Blood, 92, 3105, 10.1182/blood.V92.9.3105.421k46_3105_3114

Fowke, 1996, Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya., Lancet, 348, 1347, 10.1016/S0140-6736(95)12269-2

Hirsch, 2000, Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel., JAMA, 283, 2417, 10.1001/jama.283.18.2417

Tsui, 2004, Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug exposure., J Virol, 78, 94, 10.1128/JVI.78.1.94-103.2004